Who invested in Agomab Therapeutics?
3 investors are on record as having backed Agomab Therapeutics — Develops ALK-5 inhibitors for fibrotic diseases, in Biotech, Belgium. Each row below says whether the round came from the investor's own portfolio page or from the press.
agomab.comAgomab Therapeutics investors
Adbio PartnersEarly-stage life sciences VC backing breakthrough medical discoveries from European…their site
Canaan Management, Inc.Backs founders from fundamental discovery to mass adoption, investing in breakthrough…their site
1 more investors on record for Agomab Therapeutics.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
No round dates are on record for Agomab Therapeutics. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Agomab Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.